Relenza, the new flu treatment controversially excluded from the NHS because
a panel decided it was not cost-effective, can cause breathing difficulties in
patients with asthma. Glaxo Wellcome, which makes the drug, warned doctors of
the danger last week. The company says the number of people who have suffered
breathing difficulties after taking the drug is tiny, and that the warning is
simply a precaution. But the news is unfortunate, given that flu patients with
chronic lung disease are among the ones most likely to benefit from effective
influenza treatments.
To continue reading, today with our introductory offers
Advertisement
More from 91av
Explore the latest news, articles and features
Popular articles
Trending 91av articles
1
Are Neanderthals descendants of modern humans?
2
Electric vehicle owners could earn thousands by supporting power grid
3
Antioxidant in mushrooms may target uterus cells to ease period pain
4
Surprising male G-spot found in most detailed study of the penis yet
5
From autism to migraines, birth order may have wide-reaching effects
6
Neanderthal infants were enormous compared with modern humans
7
Collapse of key ocean current may release billions of tonnes of carbon
8
Beef is making a comeback – does it fit into a healthy diet?
9
The biggest threat to Chernobyl is no longer radiation
10
Our dreams become more emotive and symbolic as we approach death
